Dog Cerebellar Hypoplasia In Eurasier (CHP-E)

Cerebellar Hypoplasia (CHP) in Eurasier dogs is a genetic condition affecting coordination and balance. Early DNA testing for CHP helps breeders identify carriers and prevent passing this neurological disorder to puppies. By using a reliable DNA test, Eurasier owners can ensure healthier litters and improve overall breed health. Understanding the genetic risks of CHP allows for informed breeding decisions and better management of affected dogs. Regular screening is essential for maintaining the Eurasier’s quality of life and vitality. Invest in a DNA test for Cerebellar Hypoplasia to protect your Eurasier’s future. Stay proactive in safeguarding your dog’s health with advanced genetic testing.

Abbreviation : CHP-E

Analysed mutation : VLDLR c.1713delC

Inheritance : Autosomal Recessive

Acronym

CHP-E

Observed frequency

Rare

Clinical severity

Severe

Clinical classification

Neurological Diseases

Analysed mutation

VLDLR c.1713delC
p.(W572Gfs*10)

Mode of inheritance

Autosomal Recessive

Test summary:

The DNA test for Cerebellar Hypoplasia in Eurasier (CHP) helps identify carriers of this genetic disorder. CHP affects the development of the cerebellum, leading to coordination and balance issues in affected dogs. By testing, breeders can make informed decisions to avoid producing affected puppies. Early detection through DNA testing promotes healthier breeding practices within the Eurasier community. This test is a valuable tool for maintaining the breed’s overall health and well-being.

Available from the pack : Basic

This DNA test is included starting from our pack Basic — and is also part of the packs Basic, Standard, Advanced, Complete.

View DNA Test Packs →

Choose the pack that best fits your breeding or health strategy of your animals.

Understanding Cerebellar Hypoplasia in Eurasier Dogs

Cerebellar Hypoplasia (CHP) is a neurological condition characterized by the underdevelopment of the cerebellum, a part of the brain responsible for coordinating movement and balance. In Eurasier dogs, this genetic disorder can lead to a range of motor difficulties, affecting their ability to walk, run, and perform other physical activities. Symptoms often manifest early in a dog’s life, typically within the first few months, and can vary in severity from mild to profound impairment.

Genetic Basis of Cerebellar Hypoplasia

The condition is caused by specific genetic mutations that disrupt normal cerebellar development. These mutations can be identified through DNA testing, which allows breeders and owners to determine the genetic predisposition of their dogs towards CHP. Understanding the genetic basis of this condition is crucial for responsible breeding practices, as it helps reduce the risk of passing on the disorder to future generations.

Symptoms and Diagnosis

Dogs with Cerebellar Hypoplasia may exhibit a range of symptoms that can include uncoordinated movements, difficulty maintaining balance, and an abnormal gait. Some affected dogs may also display tremors or exhibit a wide stance when walking. Diagnosis typically involves a combination of clinical examination and genetic testing to confirm the presence of mutations associated with the condition. It is essential for owners to consult with a veterinarian if they suspect their dog may be affected, as early diagnosis can aid in managing the symptoms effectively.

Managing Cerebellar Hypoplasia

While there is currently no cure for Cerebellar Hypoplasia, various management strategies can help improve the quality of life for affected dogs. These may include physical therapy, which can enhance muscle strength and coordination, and environmental modifications to create a safe living space. Providing a supportive and loving environment is crucial, as dogs with CHP can lead fulfilling lives despite their challenges.

The Role of DNA Testing in Breeding

DNA testing plays a vital role in breeding programs aimed at minimizing the incidence of Cerebellar Hypoplasia in Eurasier dogs. By identifying carriers of the genetic mutations linked to this condition, breeders can make informed decisions to avoid breeding practices that may perpetuate the disorder. This proactive approach not only helps maintain the health of the breed but also promotes overall responsible breeding ethics.

Conclusion

Cerebellar Hypoplasia in Eurasier dogs is a serious genetic condition that impacts their neurological function and quality of life. Through understanding the genetic basis, symptoms, and management of CHP, owners and breeders can work together to address this disorder. DNA testing serves as a critical tool in identifying at-risk animals and fostering healthier breeding practices, ultimately leading to a stronger and more resilient breed.

Breed recognized for the test : Cerebellar Hypoplasia In Eurasier (CHP-E)

Eurasier

Interpretation of genotypes Genotype Status Learn more about the interpretation of genotypes FAQ: understanding the interpretation of result What does “Clear” mean? The animal does not carry the mutation. It will not develop the disease and will not pass it on. Is a “Carrier” serious? No. The animal is generally healthy but can transmit the mutation to its offspring. What if an animal is “Affected”? It carries two mutated copies. Clinical signs are expected depending on the disease. It should not be bred. Why are there differences between male / female? Some diseases are sex-linked, so their expression varies depending on the animal’s sex. The animal has two normal copies of the gene. No risk of developing or transmitting the disease. Heterozygous carrier: one mutated copy. The animal is usually not clinically affected but can pass the mutation to offspring. Male carrier or affected depending on the inheritance mode. Males have only one X or Y chromosome. Heterozygous female carrier: one mutated copy. She can pass the mutation on and may sometimes show mild clinical signs depending on the condition. Two mutated copies of the gene. The animal is at risk of developing the associated condition.

🧬 Interpretation of genotypes CHP-E

Genotype

Status

🟡 N/N

Non-carrier - No Risk

🟡 N/CHP-E

Carrier - No Risk

❌ CHP-E/CHP-E

Affected - At Risk

FAQ: understanding the interpretation

What does “Clear” mean?

The animal does not carry the mutation. It will not develop the disease and will not pass it on.

Is a “Carrier” serious?

No. The animal is generally healthy but can transmit the mutation to its offspring.

What if an animal is “Affected”?

It carries two mutated copies. Clinical signs are expected depending on the disease. It should not be bred.

Why are there differences between male / female?

Some diseases are sex-linked, so their expression varies depending on the animal’s sex.

Genotype Forecast for Offspring Mother Father Non-carrier Carrier Affected Favorable cross: majority Carrier risk is predominant. Majority affected Filter by mother's genotype Filter by father's genotype All Predict Offspring The animal has two normal copies of the gene. No risk of developing or transmitting the disease. Heterozygous carrier: one mutated copy. The animal is usually not clinically affected but can pass the mutation to offspring. Male carrier or affected depending on the inheritance mode. Males have only one X or Y chromosome. Heterozygous female carrier: one mutated copy. She can pass the mutation on and may sometimes show mild clinical signs depending on the condition. Two mutated copies of the gene. The animal is at risk of developing the associated condition.

Predict Offspring

Filter by mother's genotype Filter by father's genotype

N/N (Non-carrier)

N/CHP-E (Carrier)

CHP-E/CHP-E (Affected)

DNA Test FAQ

What does this DNA test detect?

This DNA test detects the mutation associated with Cerebellar Hypoplasia In Eurasier (CHP-E) in order to identify clear, carrier, or at-risk animals.

Why test a breeding animal?

DNA testing helps breeders plan safer matings and reduce the risk of transmitting the mutation to offspring.

What is the inheritance mode of this test?

The inheritance mode reported for this test is Autosomal Recessive.

Which mutation is analysed in this test?

This test analyses the mutation VLDLR c.1713delC.

Is a carrier animal necessarily affected?

Not necessarily. Interpretation depends on the inheritance pattern and the resulting genotype.

References

Gerber Martina, Fischer Andrea, Jagannathan Vidhya, Drögemüller Michaela, Drögemüller Cord, Schmidt Martin J, Bernardino Filipa, Manz Eberhard, Matiasek Kaspar, Rentmeister Kai, Leeb Tosso. A deletion in the VLDLR gene in Eurasier dogs with cerebellar hypoplasia resembling a Dandy-Walker-like malformation (DWLM). PLoS One. 2015 Feb 10;10(2):e0108917. doi: 10.1371/journal.pone.0108917. eCollection 2015.

My DNA Portal